Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Dongguan
Clinical trial register · China

Clinical Trials in Dongguan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 10 Guangzhou 3 Kaifeng 3 Lanzhou 3 Shijiazhuang 3
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University15 AstraZeneca12 Nanfang Hospital, Southern Medical University5 Biogen4 Akeso4 GlaxoSmithKline4 Janssen Research & Development, LLC3 Sanofi3 MediLink Therapeutics (Suzhou) Co., Ltd.2 Johnson & Johnson Enterprise Innovation Inc.2 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.2 Shanghai Henlius Biotech2 Guangdong Provincial People's Hospital2 Sun Yat-Sen University Cancer Center2 Alexion Pharmaceuticals, Inc.2 Guangdong Association of Clinical Trials2 DualityBio Inc.2 Pfizer2 Sichuan Baili Pharmaceutical Co., Ltd.2 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 Merck Sharp & Dohme LLC2 Zhuliling1 Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 Third Affiliated Hospital, Sun Yat-Sen University1 Tasly Pharmaceutical Group Co., Ltd1 CSL Behring1 Amgen1 Shanghai Huilun Pharmaceutical Co., Ltd.1 TJ Biopharma Co., Ltd.1 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 Zhongshan Ophthalmic Center, Sun Yat-sen University1 Fifth Affiliated Hospital, Sun Yat-Sen University1 The First Affiliated Hospital with Nanjing Medical University1 Beijing InnoCare Pharma Tech Co., Ltd.1 Guangdong Raynovent Biotech Co., Ltd1 OncoC4, Inc.1 Multitude Therapeutics Inc.1 Novartis Pharmaceuticals1 Innovent Biologics (Suzhou) Co. Ltd.1 Beijing Tiantan Hospital1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Liu yong1 Dongguan People's Hospital1 Boehringer Ingelheim1 Bellus Health Inc. - a GSK company1 RemeGen Co., Ltd.1 Vertex Pharmaceuticals Incorporated1 3D Medicines (Sichuan) Co., Ltd.1 Sunshine Lake Pharma Co., Ltd.1 Peking Union Medical College Hospital1 Betta Pharmaceuticals Co., Ltd.1 Clear sponsor filter
Target enrolment
to

Trials with a site in Dongguan

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Tasly Pharmaceutical Group Co., Ltd
Phase 3
636
Bozhou, Hefei, Suzhou, Beijing, Fuzhou, Lanzhou, Qingyang, Dongguan
2026-08-21
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/dongguan

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Dongguan that also match the filters currently applied.

How many clinical trials are recruiting in Dongguan?

1 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Dongguan), 1 studies
PhaseStudiesRecruitingShare
Phase 311100%

Most active sponsors

Lead sponsors with the most studies (Dongguan)
Lead sponsorStudiesRecruiting
Tasly Pharmaceutical Group Co., Ltd11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.